Inventiva and Chia Tai Tianqing’s Lanifibranor Advances with CDE Filing
France-based Inventiva S.A. and China’s Chia Tai Tianqing have successfully filed a clinical trial application...
Inventiva S.A.
Inventiva and Chia Tai Tianqing File Clinical Trial for Lanifibranor with CDE
France-based Inventiva S.A. and China’s Chia Tai Tianqing have filed a clinical trial application with...
Sino Biopharmaceutical Licenses Lanifibranor for NASH Treatment from Inventiva
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its subsidiary, Jiangsu Chia Tai Tianqing...